Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment

Psychiatry Research

Volumn 217, Issue 3, 2014, Pages 143-146

  Zetterberg, Henrik ^a,b   Jakobsson, Joel ^a   Redsäter, Mikael ^a   Andreasson, Ulf ^a   Pålsson, Erik ^a   Ekman, Carl Johan ^c   Sellgren, Carl ^c   Johansson, Anette GM ^c   Blennow, Kaj ^a   Landén, Mikael ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Albumin ratio; Bipolar disorder; Blood cerebrospinal fluid barrier function; Cerebrospinal fluid

Indexed keywords

ALBUMIN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BIPOLAR DISORDER; BLOOD CEREBROSPINAL FLUID BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER DYSFUNCTION; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNONEPHELOMETRY; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; BLOOD; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BLOOD-BRAIN BARRIER; FEMALE; HUMANS; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 84899999415     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.03.045     Document Type: Article

References (25)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience 2006, 7:41-53.
2. Axelsson R., Martensson E., Alling C. Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis. The British Journal of Psychiatry: The Journal of Mental Science 1982, 141:273-281.
3. Bauer K., Kornhuber J. Blood-cerebrospinal fluid barrier in schizophrenic patients. European Archives of Psychiatry and Neurological Sciences 1987, 236:257-259.
4. Bayard-Burfield L., Alling C., Blennow K., Jonsson S., Traskman-Bendz L. Impairment of the blood-CSF barrier in suicide attempters. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 1996, 6:195-199.
5. Bechter K., Reiber H., Herzog S., Fuchs D., Tumani H., Maxeiner H.G. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. Journal of Psychiatric Research 2010, 44:321-330.
6. Berman A.H., Bergman H., Palmstierna T., Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research 2005, 11:22-31.
7. Blennow K., Hampel H., Weiner M., Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Reviews Neurology 2010, 6:131-144.
8. Blennow K., Wallin A., Fredman P., Karlsson I., Gottfries C.G., Svennerholm L. Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurologica Scandinavica 1990, 81:323-326.
9. Elovaara I., Icen A., Palo J., Erkinjuntti T. CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis. Journal of the Neurological Sciences 1985, 70:73-80.
10. Hall R.C. Global assessment of functioning. A modified scale. Psychosomatics 1995, 36:267-275.
11. Jakobsson J., Stridsberg M., Zetterberg H., Blennow K., Ekman C.J., Johansson A.G., Sellgren C., Landen M. Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder. Journal of Psychiatry and Neuroscience 2013, 38:E21-E26.
12. Jakobsson J., Zetterberg H., Blennow K., Johan Ekman C., Johansson A.G., Landen M. Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder. Neuropsychopharmacology 2013, 38:664-672.
13. Kirch D.G., Kaufmann C.A., Papadopoulos N.M., Martin B., Weinberger D.R. Abnormal cerebrospinal fluid protein indices in schizophrenia. Biological Psychiatry 1985, 20:1039-1046.
14. Masserman J.H. Cerebrospinal fluid hydrodynamics IV. Clinical experimental studies. Archives of Neurology and Psychiatry 1934, 32:523-553.
15. Rapoport S.I., Schapiro M.B., May C. Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging. Archives of Neurology 2004, 61:1721-1724.
16. Reiber H. Flow rate of cerebrospinal fluid (CSF)-a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. Journal of the Neurological Sciences 1994, 122:189-203.
17. Reiber H., Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. Journal of the Neurological Sciences 2001, 184:101-122.
18. Ryden E., Thase M.E., Straht D., Aberg-Wistedt A., Bejerot S., Landen M. A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatrica Scandinavica 2009, 120:239-246.
19. Sachs G.S., Thase M.E., Otto M.W., Bauer M., Miklowitz D., Wisniewski S.R., Lavori P., Lebowitz B., Rudorfer M., Frank E., Nierenberg A.A., Fava M., Bowden C., Ketter T., Marangell L., Calabrese J., Kupfer D., Rosenbaum J.F. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry 2003, 53:1028-1042.
20. Saija A., Princi P., Imperatore C., De Pasquale R., Costa G. Ageing influences haloperidol-induced changes in the permeability of the blood-brain barrier in the rat. The Journal of Pharmacy and Pharmacology 1992, 44:450-452.
21. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption-II. Addiction 1993, 88:791-804.
22. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry 1998, 59(Suppl. 20):S22-S33. (quiz 34-57).
23. Tibbling G., Link H., Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scandinavian Journal of Clinical and Laboratory Investigation 1977, 37:385-390.
24. Townsend J.B., Ziedonis D.M., Bryan R.M., Brennan R.W., Page R.B. Choroid plexus blood flow: evidence for dopaminergic influence. Brain Research 1984, 290:165-169.
25. Wallin A., Blennow K., Fredman P., Gottfries C.G., Karlsson I., Svennerholm L. Blood brain barrier function in vascular dementia. Acta Neurologica Scandinavica 1990, 81:318-322.